| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |